U.S. Machinery Stock News

If you are wondering whether IMAX at around US$35.07 is still good value after its run, this article will walk through what the current share price might be implying. The stock has had a mixed run recently, with a 2.8% gain over the last week, a 10.2% decline over the last month, and returns of 54.0% over 1 year, 120.6% over 3 years, and 88.3% over 5 years. Recent attention on IMAX has centered on box office trends and its position in premium large format cinema, as investors assess how...

Duos Technologies Group, through its Duos Edge AI subsidiary, recently deployed a patented modular Edge Data Center in Hereford, Texas, in partnership with the Hereford Independent School District to bolster low-latency computing for education and local users. This initiative highlights Duos’ push into rural and underserved markets, using repeatable, capital-efficient edge infrastructure that targets recurring revenue and broader digital access. We’ll now examine how this rural edge data...

If you are wondering whether Warrior Met Coal's current price reflects its true worth, you are not alone. The stock invites a closer look at what you are actually paying for the underlying business. At a recent close of US$102.08, the share price sits alongside returns of 11.2% over 7 days, 22.2% over 30 days, 14.0% year to date and 90.5% over 1 year, with a very large gain over 5 years. These price moves sit against ongoing interest in coal producers and how investors are weighing long term...

If you are wondering whether Old National Bancorp at around US$22.85 is offering fair value or a potential opportunity, it helps to step back and look at what the recent share performance is really telling you. The stock price return data is mixed, with a 0.8% decline over the past 7 days and a 0.6% decline over 30 days, set against gains of 1.3% year to date, 3.0% over 1 year, 41.0% over 3 years, and 48.2% over 5 years. These moves sit against a backdrop where investors are continuously...

If you are wondering whether FTI Consulting at around US$175 per share is offering fair value or a potential mispricing, you are not alone. The stock has been relatively steady in the short term, with a 0.4% decline over the last 7 days, a 2.8% return over the last month, and a 2.9% return year to date. This sits alongside a 9.2% decline over the last year, but gains of 13.0% over 3 years and 50.2% over 5 years. Recent attention on FTI Consulting has reflected how the market is reassessing...

GSI Technology has announced a government-funded proof-of-concept with Israel’s G2 Tech and two agencies, including the U.S. Department of War, to integrate its Gemini-II compute-in-memory APU into Sentinel, an autonomous perimeter security system coordinating drones and cameras for real-time monitoring and response. Around US$1,000,000 in expected funding to optimize and integrate Gemini-II into a mission-critical defense application underscores the technology’s relevance for on-device AI...

If you are wondering whether Grab Holdings is offering fair value at its recent price of US$4.63, you are not alone. This article is built to help you frame that question clearly. The share price has seen a 8.9% decline over the last week and a 7.8% decline over the past month, although it is up 3.8% over 1 year and 24.8% over 3 years, while still sitting 68.9% below its 5 year level. These moves come as investors continue to weigh the prospects of Grab's core ride hailing, deliveries, and...

If you are wondering whether Solventum is offering fair value or represents an opportunity on sale right now, this article walks through what the current price might be indicating. The stock most recently closed at US$80.05, with returns of 11.1% over the past year, a 1.3% gain year to date, and declines of 5.0% over 7 days and 2.2% over 30 days. Recent headlines around Solventum have focused on its position within the healthcare sector and investor interest in how the business trades as a...

If you are wondering whether Stoke Therapeutics at around US$30.97 is still offering value or already pricing in a lot of optimism, you are not alone. The stock has seen a 226.3% return over the last year, although the past 7 days and 30 days brought declines of 11.9% and 6.1% respectively, and year to date it is close to flat at 0.2%. Recent attention on Stoke Therapeutics has centered on its position in the pharmaceuticals and biotech space, where investors often react quickly to clinical...

Bitmine Immersion Technologies (BMNR) has opened Q1 2026 with revenue of US$2.3 million and Basic EPS of a US$15.98 loss, while trailing 12 month figures show revenue of US$7.2 million and Basic EPS of a US$46.42 loss. Over the past year, revenue has moved from US$3.3 million in Q4 2024 to US$6.1 million on a trailing 12 month basis in Q4 2025, alongside a shift in Basic EPS from a US$1.32 loss to US$13.60. With the latest quarter firmly in loss making territory, the focus now is on how...

If you are wondering whether Federal Home Loan Mortgage at US$9.18 is still good value after its run in recent years, you are not alone. The stock has seen a 62.2% return over the last year, even though the 7 day, 30 day and year to date returns of 9.6%, 9.9% and 11.3% declines suggest some recent cooling. Recent news coverage has focused on Federal Home Loan Mortgage's role in the broader US housing finance system and the ongoing investor interest in government sponsored entities. This...

Canaan Inc. recently announced a 3.0 MW proof-of-concept with Bitforest Investment in Manitoba, where its Avalon liquid-cooled computing servers will recycle waste heat to support greenhouse operations while targeting high uptime and low power costs. This project highlights how bitcoin mining infrastructure can be repurposed as an energy-efficient heat source for agriculture, potentially broadening Canaan’s role beyond traditional mining hardware. We’ll now examine how this heat-reuse...

Why OPKO Health is on investors’ radar today OPKO Health (OPK) has drawn attention after recent trading left the share price at $1.30, with the stock showing mixed returns over the past week, month, past 3 months, and year. See our latest analysis for OPKO Health. At the current US$1.30 share price, OPKO Health’s recent 1 day and 3 month share price declines, alongside a 1 year total shareholder return loss of 11.56%, suggest that momentum has been fading, even though there has been a small...

Bank of America (BAC) FY 2025 earnings snapshot Bank of America (BAC) has wrapped up FY 2025 with fourth quarter revenue of US$27.1b and basic EPS of US$0.99, supported by trailing twelve month revenue of US$107.4b and EPS of US$3.86. The bank has seen revenue move from US$96.1b and EPS of US$3.25 on a trailing basis at the end of 2024 to US$107.4b and US$3.86 respectively, while FY 2025 net income excluding extra items came in at US$29.1b. Together with a trailing net profit margin of 27%...

Wells Fargo (WFC) just wrapped up FY 2025 with Q4 revenue of US$20.3b and basic EPS of US$1.64, anchored by quarterly net income of US$5.1b. Over the past few quarters, the bank has seen revenue move from US$19.3b in Q4 2024 to US$19.2b in Q1 2025, US$19.8b in Q2, US$20.8b in Q3 and US$20.3b in Q4. EPS tracked from US$1.45 to US$1.41, US$1.61, US$1.68 and US$1.64 over the same stretch. This sets up a year where margins and profitability sit squarely in focus for investors. See our full...

Why the latest sales update matters for Savers Value Village (SVV) Savers Value Village (SVV) has drawn fresh attention after reporting preliminary net sales for its fourth quarter and fiscal 2025, alongside an update on share repurchases and upcoming investor conference participation. See our latest analysis for Savers Value Village. The preliminary sales update and active buyback program appear to have shifted sentiment, with a 10.2% 7 day share price return and 10.9% year to date share...

If you are wondering whether Natera's current share price lines up with its underlying value, you are not alone. This article is built to help you connect the dots. Natera's stock closed at US$239.19, with returns of 4.5% year to date and about 42% over the past year. The last week showed a small 0.2% decline, the past month showed a 5.2% gain, and the three year figure is very large. Recent attention on Natera has been shaped by company specific developments and sector wide interest in...

If you are wondering whether Constellium's current share price still offers value, you are not alone. Many investors are asking the same question after its recent run. The stock last closed at US$22.77, with returns of 13.9% over 7 days, 23.9% over 30 days, 15.2% year to date and 109.9% over 1 year. This naturally raises questions about what is already priced in. Recent attention on Constellium has centered on its position as an aluminum products supplier across automotive, packaging and...

Earlier in January 2026, Monte Rosa Therapeutics completed a roughly US$300.00 million follow-on equity offering, including 11,125,000 common shares at US$24 each and 1,375,000 pre-funded warrants, shortly after releasing positive interim Phase 1 data for its NEK7-directed degrader MRT-8102 in inflammatory conditions. The Phase 1 results, showing deep NEK7 degradation alongside broad reductions in inflammatory markers such as hsCRP and IL-6 with a favorable safety profile in higher...

Concrete Pumping Holdings (BBCP) just wrapped up FY 2025 with fourth quarter revenue of US$108.8 million and basic EPS of US$0.10, alongside net income of US$4.9 million, setting the tone for how the year closed out. The company has seen quarterly revenue move from US$111.5 million and EPS of US$0.17 in Q4 FY 2024 to US$108.8 million and EPS of US$0.10 in Q4 FY 2025, while trailing twelve month net profit margins sit at 1.2% compared with 3.4% a year earlier, so investors are weighing modest...

Earlier this week, Qiagen N.V. outlined its 2026 priorities at the J.P. Morgan Healthcare Conference and the German Investment Seminar, following a special US$2.29 cash dividend with an ex-dividend date of January 8, 2026. The company underscored plans to expand its five core growth pillars, integrate the Parse Biosciences acquisition for single-cell analysis, and pursue automation, AI, and targeted M&A to reach a combined US$2.00 billion in pillar sales by 2028. We’ll now examine how...

If you are wondering whether Brookfield Business Partners at around US$34.85 offers good value today, you are not alone. This article breaks down what that price could mean for long term investors. The unit price has moved 2.7% over the last week, while the 30 day return is a 0.9% decline and the 1 year return sits at 58.1%, with a 3 year return of 91.5% and 5 year return of 42.7%. Recent attention on Brookfield Business Partners has centered on its position as a listed arm of the wider...

Bank of New York Mellon Corporation (BK) has wrapped up FY 2025 with fourth quarter total revenue of US$5.2 billion and basic EPS of US$2.05, alongside net income of US$1.4 billion, while the trailing 12 month view shows revenue of US$20.1 billion, EPS of US$7.47 and net income of US$5.3 billion. Over recent quarters the company has seen quarterly revenue move from US$4.8 billion in Q4 2024 to US$5.0 billion in Q2 2025 and then to US$5.2 billion in Q4 2025, with quarterly basic EPS stepping...

Park Aerospace (PKE) just posted its Q3 2026 numbers, with revenue of $17.3 million and net income of $2.95 million, translating to basic EPS of $0.15. The company has seen revenue move from $16.7 million in Q2 2025 to $14.4 million in Q3 2025 and then to $17.3 million in Q3 2026, while quarterly EPS over that stretch has ranged from $0.10 to $0.15 as earnings on a trailing 12 month basis reached $8.68 million. With net profit margins on a trailing basis higher than a year ago, the latest...